Dubberke, Erik R.
Orenstein, Robert
Khanna, Sahil
Guthmueller, Beth
Lee, Christine
Clinical trials referenced in this document:
Documents that mention this clinical trial
Final Results from a Phase 2b Randomized, Placebo-Controlled Clinical Trial of RBX2660: A Microbiota-Based Drug for the Prevention of Recurrent Clostridioides difficile Infection
https://doi.org/10.1007/s40121-022-00744-3
Investigational drug therapies currently in early-stage clinical development for the treatment of clostridioides (clostridium) difficile infection
https://doi.org/10.1080/13543784.2019.1581763
Article History
Received: 14 October 2022
Accepted: 1 December 2022
First Online: 21 December 2022
Change Date: 27 March 2023
Change Type: Update
Change Details: A peer-reviewed infographic was retrospectively added to this publication.